Skip to main content

Table 6 Cumulative incidence of MACEs at 12 months follow up period

From: Short- and long-term outcomes following percutaneous coronary intervention in hepatitis C virus seropositive patients

Variables

Group (1)

Group (2)

P value

TLR

 Yes

13 (6.5%)

11 (5.5%)

0.674

TVR

 Yes

3 (1.5%)

3 (1.5%)

1.00

CABG

 Yes

1 (0.5%)

2 (1%)

1.00

CVS

 Yes

2 (1%)

1 (0.5%)

1.00

MI

 Yes

5 (2.5%)

3 (1.5%)

0.72

Major bleeding

 Yes

0

0

 

Cardiac death

 Yes

3 (1.5%)

2 (1%)

0.68

Non-Cardiac death

 Yes

0

0

 

MACEs

 Yes

27 (13.5%)

22 (11%)

0.446

Stent thrombosis

 Yes

2 (1%)

2 (1%)

1.00

  1. Abbreviations: CABG coronary artery bypass graft, CVS cerebrovascular stroke, MACEs major adverse cardiovascular events, MI myocardial infarction, TLR target lesion revascularization, TVR target vessel revascularization